Latest News

China’s President Xi Jinping likely to skip G20 summit in India

NEW DELHI/BEIJING, Aug 31 (Reuters) – China’s President Xi Jinping is likely to skip a summit of G20 leaders in India next week, sources familiar with the matter in India and China told Reuters. Two Indian officials, one diplomat based in China and one official working for the government of another G20 country said Premier Li Qiang is expected to represent Beijing at the Sept. 9-10 meeting in New Delhi. Spokespersons for the Indian and Chinese foreign ministries did not respond to requests for comment. The summit in India had been viewed as a venue at which Xi may meet

India’s economic growth set to accelerate to its fastest in a year

An employee works inside an engineering goods export unit in the manufacturing hub of Faridabad on the outskirts of New Delhi, India, January 13, 2023. REUTERS/Manoj Kumar

India’s economy grew at its fastest pace in a year in the April-June quarter, driven by services and manufacturing, data is expected to show on Thursday, though economists warn of a slowdown ahead. According to the median forecast (INGDPQ=ECI) in a Reuters poll of economists, India’s gross domestic product (GDP) grew 7.7% in the past quarter, up from 6.1% growth in the previous quarter and its fastest expansion since April-June 2022. Economists say lower commodity prices helped manufacturers increase margins and offset the impact of 250 basis points of cumulative interest rate increases since May 2022. Suvodeep Rakshit, economist at Kotak Institutional

Medicare’s Drug Price Cut Initiative, starting with 10 costing it $50.5 billion annually : Health policy analyst explains why negotiations are promising but will take year

Medicare's Drug Price Cut Initiative, starting with 10 costing it $50.5 billion annually : Health policy analyst explains why negotiations are promising but will take year

The Biden administration released on Aug. 29, 2023, a list of the first 10 drugs that will be up for negotiations with pharmaceutical companies over their Medicare prices. The drugs are purchased through Medicare Part D, a prescription drug coverage program for Americans ages 65 and older. The 10 medications accounted for more than US$50.5 billion in gross costs between June 1, 2022, and May 31, 2023. Provisions authorizing these negotiations were part of the Inflation Reduction Act which Congress passed in 2022, allowing Medicare to negotiate drug prices for the first time. Pending successful negotiations, these changes would amount

August’s Rare Super Blue Moon in Over a Decade!

August's Rare Super Blue Moon in Over a Decade!

Captivating the Cosmos: August’s Rare Super Blue Moon Celestial marvel of cosmic proportions – none other than the rare super blue moon of August. This fantastic event, gracing the night time sky with its spell binding presence, is a spectacle that ignites the imagination and fuels our interest about the cosmos. The allure of the super blue moon lies not only in its visual splendor but also in its infrequency. What provides a touch of mystique to this celestial display is the belief that it is the remaining of its type we’re going to witness for extra than a decade.

1 … 1,547 1,548 1,549 1,550 1,551 … 1,566